Danaher Corporation $DHR Stock Position Trimmed by LaFleur & Godfrey LLC

LaFleur & Godfrey LLC trimmed its position in shares of Danaher Corporation (NYSE:DHR) by 28.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 18,642 shares of the conglomerate’s stock after selling 7,518 shares during the period. LaFleur & Godfrey LLC’s holdings in Danaher were worth $3,696,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in DHR. WFA of San Diego LLC bought a new position in Danaher in the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in Danaher during the 2nd quarter worth $27,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher during the 3rd quarter worth $27,000. TruNorth Capital Management LLC bought a new position in shares of Danaher in the third quarter worth $28,000. Finally, Tripletail Wealth Management LLC acquired a new position in shares of Danaher during the third quarter valued at $31,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on DHR. JPMorgan Chase & Co. increased their target price on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Guggenheim boosted their target price on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 2nd. TD Cowen reaffirmed a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Finally, Argus set a $265.00 price target on Danaher in a research report on Wednesday, January 14th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $253.86.

Danaher Trading Down 0.8%

Shares of NYSE:DHR opened at $209.56 on Monday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The stock has a market capitalization of $148.02 billion, a price-to-earnings ratio of 41.58, a PEG ratio of 2.83 and a beta of 0.91. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80. The company has a 50 day moving average price of $226.85 and a 200 day moving average price of $216.03.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.14 EPS. On average, research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a $0.32 dividend. The ex-dividend date was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 25.40%.

Insider Buying and Selling at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.20% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.